Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferumoxytol vs Ferrous Sulfate in Antepartum Iron Deficiency Anemia
NCT04253626Phase 3Completed
- Sponsor
- Stanford University
- Start
- Jan 2021
- Primary completion
- Jul 2024
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ferumoxytol in iron deficiency anemia (IDA) (2 arms), sponsored by Stanford University. Primary endpoint: Median Change in Hemoglobin Value Before and After Intervention at 6 weeks. Started Jan 2021; status: completed.
02
Drugs
ferumoxytol
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT04253626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04253626.